Fragmin (Dalteparin)

Buy Fragmin from Europe at more than a 50% discount below US prices.

Non-english packaging is often present for European medicines- English label and English insert included. Plan in advance - allow us 7 days to ship this brand name medicine.

According to the European Medicines Agency, brand name Fragmin originating from Europe is manufactured at the following site(s):Pfizer Manufacturing Belgium NV Rijksweg 12 B-2870 Puurs BelgiumCatalent France Limoges S.A.S Z.I. Nord 53 rue de Dion Bouton 87280 Limoges France

Information about Fragmin (Dalteparin)

Fragmin is a low molecular weight heparin (LMWH) that acts as an anticoagulant. It is used to prevent and treat thromboembolic disorders, including deep vein thrombosis (DVT) and pulmonary embolism (PE).

Product Highlights

• Inhibits factor Xa and, to a lesser extent, factor IIa (thrombin), preventing the formation of blood clots.
• Prevention of venous thromboembolism (VTE) in patients undergoing surgery and those receiving medical treatment.
• Treatment of DVT and PE.
• Prevention of clot formation in patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI).

Key Ingredient

• Dalteparin

Key Benefits

• Reduces the risk of blood clots in various clinical settings.
• Subcutaneous injection allows for easy self-administration.
• Unlike unfractionated heparin, routine monitoring of anticoagulation levels is often not necessary.

Direction of Use

• Administer via subcutaneous injection in the abdominal area, rotating injection sites.
• Follow healthcare provider's instructions for the appropriate dose based on the indication.
• Can be given with or without food, as directed.

Safety Concerns

• Increased risk of bleeding, which may be severe; monitor for signs of bleeding.
• Possible decrease in platelet count; monitor platelet levels regularly.
• May cause pain, redness, or bruising at the injection site.
• Rare but possible; watch for symptoms such as rash or difficulty breathing.

Avoid Fragmin (Dalteparin) If

• You have a known allergy to dalteparin or any of its components.
• You have active major bleeding or a condition that increases bleeding risk (e.g., severe thrombocytopenia).
• You have a history of heparin-induced thrombocytopenia (HIT).
• You are undergoing certain surgical procedures where anticoagulation could pose a risk.
• You are pregnant or breastfeeding without discussing it with a healthcare provider.